Download This Paper
Preprints with The Lancet is a collaboration between The Lancet Group of journals and SSRN to facilitate the open sharing of preprints for early engagement, community comment, and collaboration. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early-stage research papers that have not been peer-reviewed. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. The findings should not be used for clinical or public health decision-making or presented without highlighting these facts. For more information, please see the FAQs.
Creatine Metabolism and Carnitine Shuttle System as Potential Diagnostic and Prognostic Biomarkers of Gonadotropin Replacement Therapy in Young Males With Panhypopituitarism
34 Pages Posted: 20 Nov 2020
More...Abstract
Background: Panhypopituitarism (Hypo-Pit) is characterized by a complete deficiency of anterior pituitary hormones. Besides hormone metabolism, the serum metabolomics in Hypo-Pit are largely unknown. We aimed to identify metabolic changes in Hypo-Pit to explain its clinical phenotype and to ultimately explore potential biomarkers to aid in diagnosis and personalized treatment.
Methods: Metabolic profiles were collected in 134 males with Hypo-Pit and 90 same-aged healthy controls by non-targeted metabolomics in serum. Prognostic marker for human chorionic gonadotropin (hCG) therapy was validated in another cohort including 95 males with congenital Hypo-Pit.
Results: 59 metabolites altered significantly in Hypo-Pit. The most discriminating pathways included steroid metabolism, arginine and proline metabolism, β-fatty acid and glycerophospholipid metabolism. Hypo-Pit shows significantly higher creatine and its precursors, but a relative lower creatinine, indicates creatine metabolism disorder, conform to decreased muscle mass and muscle strength; Hypo-Pit also shows a significantly lower long-chain acyl-carnitines, but a higher free carnitine, indicates carnitine shuttle disorder, consistent with the symptom of decreased fatty acid oxidation. In addition, the creatine/creatinine and Decanoyl-L-carnitine/L-carnitine ratio could serve as promising diagnostic biomarkers for Hypo-Pit, which showed an area under the ROC curve (AUC) of 0.976 and 0.988, respectively. Moreover, the serum creatinine and acyl-carnitines/L-carnitine were shown as promising predictors of hCG therapy, with AUC of 0.746 and 0.713 in discriminating the hCG-sensitive and resistant patients.
Conclusions: This is the first study to link a framework of metabolic perturbations with the pathophysiology, diagnostic and prognostic biomarkers of Hypo-Pit.
Funding Statement: The present study was supported by scientific research project of Shanghai Health and Family Planning Commission (grant no. 201840160), Natural Science Foundation of Shanghai (20ZR1434100; Shanghai, China), the Science and Technology Commission of Jiading District (JDKW‐2017‐W09 and JDKW‐2017‐W11; Shanghai, China), and the Interdisciplinary funding of Shanghai Jiao Tong University (YG2017QN57; Shanghai, China), Ruijin Hospital North for Young Talents (grant no. 2017RCPY-A01, 2017RCPY-B10 and 2017RCPY-C01; Shanghai, China).
Declaration of Interests: There is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.
Ethics Approval Statement: The study was approved by the ethics committee of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine. All participants or their legal guardians provided written informed consent.
Keywords: Panhypopituitarism, gonadotropin replacement therapy, untargeted metabolomics, creatine metabolism, carnitine shuttle system
Suggested Citation: Suggested Citation